首页> 外文期刊>Chest: The Journal of Circulation, Respiration and Related Systems >EIF2AK4 Mutations in pulmonary capillary hemangiomatosis
【24h】

EIF2AK4 Mutations in pulmonary capillary hemangiomatosis

机译:EIF2AK4肺毛细血管血管瘤病的突变

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Pulmonary capillary hemangiomatosis (PCH) is a rare disease of capillary proliferation of unknown cause and with a high mortality. Families with multiple affected individuals with PCH suggest a heritable cause although the genetic etiology remains unknown. Methods: We used exome sequencing to identify a candidate gene for PCH in a family with two affected brothers. We then screened 11 unrelated patients with familial (n 5 1) or sporadic (n 5 10) PCH for mutations. Results: Using exome sequencing, we identifi ed compound mutations in eukaryotic translation initiation factor 2 a kinase 4 ( EIF2AK4 ) (formerly known as GCN2 ) in both affected brothers. Both parents and an unaffected sister were heterozygous carriers. In addition, we identifi ed two EIF2AK4 mutations in each of two of 10 unrelated individuals with sporadic PCH. EIF2AK4 belongs to a family of kinases that regulate angiogenesis in response to cellular stress. Conclusions: Mutations in EIF2AK4 are likely to cause autosomal-recessive PCH in familial and some nonfamilial cases. CHEST 2014; 145(2):231-236.
机译:背景:肺毛细血管血管瘤(PCH)是一种罕见的毛细血管增生性疾病,病因不明,死亡率很高。尽管遗传病因仍未知,但有多个患有PCH的受影响个体的家庭提出了遗传原因。方法:我们使用外显子组测序来鉴定有两个受影响兄弟的家庭中PCH的候选基因。然后,我们筛选了11例家族性(n 5 1)或散发性(n 5 10)PCH无关患者的突变。结果:使用外显子组测序,我们在两个受影响的兄弟中鉴定了真核翻译起始因子2 a激酶4(EIF2AK4)(以前称为GCN2)中的复合突变。父母和未受影响的姐妹都是杂合子携带者。此外,我们在散发性PCH的10个无亲缘关系的个体中,有两个分别鉴定出两个EIF2AK4突变。 EIF2AK4属于激酶家族,可响应细胞应激而调节血管生成。结论:EIF2AK4的突变可能在家族性和非家族性病例中引起常染色体隐性PCH。胸部2014; 145(2):231-236。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号